These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26203600)

  • 1. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets.
    Keskin M; Savaş-Erdeve Ş; Sağsak E; Çetinkaya S; Aycan Z
    J Pediatr Endocrinol Metab; 2015 Nov; 28(11-12):1333-7. PubMed ID: 26203600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of therapy in X-linked hypophosphatemic rickets.
    Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
    N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse.
    Alon U; Donaldson DL; Hellerstein S; Warady BA; Harris DJ
    J Pediatr; 1992 Jun; 120(6):899-905. PubMed ID: 1317418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrocalcinosis and its relationship to treatment of hereditary rickets.
    Goodyer PR; Kronick JB; Jequier S; Reade TM; Scriver CR
    J Pediatr; 1987 Nov; 111(5):700-4. PubMed ID: 2822887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth.
    Kooh SW; Binet A; Daneman A
    Clin Invest Med; 1994 Apr; 17(2):123-30. PubMed ID: 8004848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary hypophosphatemic rickets with hypercalciuria: case report.
    Areses-Trapote R; López-García JA; Ubetagoyena-Arrieta M; Eizaguirre A; Sáez-Villaverde R
    Nefrologia; 2012 Jul; 32(4):529-34. PubMed ID: 22806288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide Turkish Cohort Study of Hypophosphatemic Rickets.
    Şıklar Z; Turan S; Bereket A; Baş F; Güran T; Akberzade A; Abacı A; Demir K; Böber E; Özbek MN; Kara C; Poyrazoğlu Ş; Aydın M; Kardelen A; Tarım Ö; Eren E; Hatipoğlu N; Büyükinan M; Akyürek N; Çetinkaya S; Bayramoğlu E; Selver Eklioğlu B; Uçaktürk A; Abalı S; Gökşen D; Kor Y; Ünal E; Esen İ; Yıldırım R; Akın O; Çayır A; Dilek E; Kırel B; Anık A; Çatlı G; Berberoğlu M
    J Clin Res Pediatr Endocrinol; 2020 Jun; 12(2):150-159. PubMed ID: 31514490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxaluria is not a cause of nephrocalcinosis in phosphate-treated patients with hereditary hypophosphatemic rickets.
    Tieder M; Blonder J; Strauss S; Shaked U; Maor J; Gabizon D; Manor H; Sela BA
    Nephron; 1993; 64(4):526-31. PubMed ID: 8396209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guide-lines to the treatment of patients with X-linked hypophosphatemic rickets.
    Reusz GS
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):147-51. PubMed ID: 8578931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure in hypophosphatemic rickets: complications from high-dose phosphate therapy.
    Sun GE; Suer O; Carpenter TO; Tan CD; Li-Ng M
    Endocr Pract; 2013; 19(1):e8-e11. PubMed ID: 23186962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of children with hypophosphataemic rickets].
    Rahbek ET; Nielsen LH; Beck-Nielsen SS; Christesen HT
    Ugeskr Laeger; 2014 Feb; 176(9A):V10130629. PubMed ID: 25350412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypophosphatemic Rickets.
    Bitzan M; Goodyer PR
    Pediatr Clin North Am; 2019 Feb; 66(1):179-207. PubMed ID: 30454743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence suggesting hyperoxaluria as a cause of nephrocalcinosis in phosphate-treated hypophosphataemic rickets.
    Reusz GS; Latta K; Hoyer PF; Byrd DJ; Ehrich JH; Brodehl J
    Lancet; 1990 May; 335(8700):1240-3. PubMed ID: 1971321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets.
    Mäkitie O; Kooh SW; Sochett E
    Clin Endocrinol (Oxf); 2003 Feb; 58(2):163-8. PubMed ID: 12580931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrocalcinosis, hyperparathyroidism, and renal failure in familial hypophosphatemic rickets.
    Alon U; Lovell HB; Donaldson DL
    Clin Pediatr (Phila); 1992 Mar; 31(3):180-3. PubMed ID: 1547591
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutics of X-linked hypophosphatemic rickets.
    Latta K; Hisano S; Chan JC
    Pediatr Nephrol; 1993 Dec; 7(6):744-8. PubMed ID: 8130097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
    Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
    Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X linked hypophosphataemia: treatment, height gain, and nephrocalcinosis.
    Reusz GS; Hoyer PF; Lucas M; Krohn HP; Ehrich JH; Brodehl J
    Arch Dis Child; 1990 Oct; 65(10):1125-8. PubMed ID: 2248503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management and complications of X-linked hypophosphatemic vitamin D resistant rickets.
    Ono T; Seino Y
    Acta Paediatr Jpn; 1997 Aug; 39(4):503-7. PubMed ID: 9316301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.